Eurofins Viracor BioPharma (United States)

Eurofins Viracor BioPharma is a subsidiary of Eurofins that provides drug development solutions to pharmaceutical and contract research organizations, offering complex/esoteric testing and assay development to support Phase 1-4 clinical trials. It describes itself as a leader in infectious disease and vaccines, developing and validating assays, immunology and allergy testing, with over 40 years of specialized expertise. The company has expanded its bioanalytical capabilities, integrating more than 20 years of bioanalytical expertise into its Lenexa, Kansas laboratory, and reports that 9 of the top 10 global pharma companies partner with it.

Eurofins Viracor BioPharma is a subsidiary of Eurofins. It states that for more than 40 years it has been dedicated to helping clients by providing high-quality, accurate results to evaluate the effects of drug candidates across all major therapeutic categories, and that it has been supporting clients through multiple phases of drug development for over thirty-five years. The company has significantly expanded its bioanalytical capabilities, integrating more than 20 years of bioanalytical expertise into its state-of-the-art Lenexa, Kansas laboratory, purpose-built to meet the demands of modern clinical trials.

A trusted laboratory partner helping to accelerate BioPharma studies through innovative scientific solutions and laboratory services.

• Bioanalytical testing

• Custom assay development/validation

• Cell-based assays

• PBMC isolation

1. 1Eurofins Viracor BioPharma - Clinical Research CROeurofins-viracorbiopharma.com
2. 2Eurofins Viracor BioPharma Company Mission and Historyeurofins-viracorbiopharma.com
3. 3Eurofins Viracor BioPharma Clinical Trial Testing - About Useurofins-viracorbiopharma.com
4. 4Eurofins Viracor BioPharma Clinical Trial Analytical Testing Laboratory Serviceseurofins-viracorbiopharma.com